Stock ANIX ANIXA BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Anixa Biosciences, Inc.

Equities

ANIX

US03528H1095

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
3.23 USD +8.39% Intraday chart for Anixa Biosciences, Inc. +3.53% -16.75%
18/04 Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board CI
12/03 Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

Evolution of the average Target Price on Anixa Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0c8cdd61e09.SgOccZ18fOLb7IusLrwEu7aCbtuLIM2r5kyiXg_1CXk.PXn1SNc9K7S_s-X8RPtD-IHHC7DgU7mejzvpbTaYeiksa6wU5UkYz4TU-A~6fc3a7954505292f95a889e9bcfbea1b

Analyst Recommendations on Anixa Biosciences, Inc.

North American Morning Briefing : Nasdaq Futures Slip as Rate Rise Fears Weigh DJ
HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating MT
Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating MT
Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target MT
ANIXA BIOSCIENCES : HC Wainwright Starts Anixa Biosciences at Buy with $11 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.23 USD
Average target price
12 USD
Spread / Average Target
+271.52%
High Price Target
12 USD
Spread / Highest target
+271.52%
Low Price Target
12 USD
Spread / Lowest Target
+271.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Anixa Biosciences, Inc.

HC Wainwright
Chardan Research

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ANIX Stock
  4. Consensus Anixa Biosciences, Inc.